The Home Healthcare Market is estimated to be valued at US$ 384584.69 Mn in 2023 and is expected to exhibit a CAGR of 8.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
The home healthcare market constitutes medical products and services used for curative, rehabilitative, and preventive healthcare treatment of patients at their residences. This includes home infusion therapy, respiratory therapy, continuous ambulatory peritoneal dialysis (CAPD), and electronic home monitoring devices. Home healthcare helps reduce healthcare costs by lowering hospital admission rates and length of stay. It provides patients comfort and rehabilitation in the familiar surroundings of their homes.

Market Dynamics:
Two key drivers anticipated to boost the home healthcare market during the forecast period are:
1) Growing Geriatric Population: The aging population is more prone to chronic diseases like diabetes, cancer, respiratory diseases etc. Home healthcare allows elderly patients to get treatment while staying in the comfort of their homes, avoiding hospital stays. This drives the demand in the market.
2) Increased Patient Preference for Home Healthcare: There is a shift in preference towards receiving medical treatment at home rather than in healthcare facilities. Home healthcare provides convenience and lowers out of pocket costs for patients. It also enables early discharges from hospitals with continued care at home. This increasing preference is expected to fuel the home healthcare market growth over the next few years.
Segment Analysis
The global home healthcare market can be segmented on the basis of product (testing, screening and monitoring products, therapeutic products and home healthcare mobility care products), service (rehabilitation services, telehealth and telemedicine services, infusion therapy services, respiratory therapy services, unskilled home healthcare services and skilled nursing services) and software (agency software, clinical management systems and telehealth solutions). Currently, the therapeutic product segment is dominating the market as it comprises of essential medical supplies required for the patients undergoing treatment at home. With increasing prevalence of chronic diseases requiring long term care, the demand for therapeutic products such as ostomy care bags, fecal management system and other disposables is increasing at a high rate, thereby driving the growth of this segment over the forecast period.

PEST Analysis
Political: Governments across the globe are increasingly focusing on facilitating home healthcare as it provides an economically viable option for treating patients. Favorable regulations are being introduced to support home healthcare practices and coverage.
Economic: Growing healthcare costs have compelled governments to shift towards cost-effective modes of treatment like home healthcare. It reduces the per patient expenditure for the governments significantly.
Social: Changing lifestyles and increase in number of working women have boosted the demand for convenient treatment options like home healthcare. With growing preference for home monitoring over hospital stays, this sector is gaining prominence.
Technological: Advent of remote patient monitoring devices, telehealth solutions and mHealth apps have enabled provision of quality healthcare at home. Advancements in connected medical devices have further augmented the delivery of care and treatment from the comfort of home.

Key Takeaways
The Global Home Healthcare Market Size is expected to witness high growth, exhibiting CAGR of 8.2% over the forecast period, due to increasing prevalence of chronic diseases, rapid aging of population, growing need for cost-effective healthcare delivery, and technological advancements in home care medical devices and telehealth solutions.

Regional analysis
North America dominates the global home healthcare market and is expected to continue its dominance over the forecast period. This can be attributed to the rising healthcare costs and growing geriatric population in the US requiring long-term care. Furthermore, supportive regulations and improving reimbursement scenario in the US propel the demand for home healthcare services.

Key players
Key players operating in the home healthcare market are 3M, Abbott Laboratories, Bayer AG, Becton, Cardinal Health, F. Hoffmann-La Roche Ltd., GE Healthcare, Gentiva Health Services, Inc., Invacare Corporation, Johnson & Johnson Services, Inc., The Linde Group, Medtronic, Inc., Omron Healthcare, Inc., AdaptHealth, Current Health, Baxter International Inc., Optum, Outset Medical, and Regeneron Pharmaceuticals, Inc. 3M, Abbott and Johnson & Johnson are the major market leaders owing to their diverse product portfolio and widespread market presence.

Read More: https://www.ukwebwire.com/home-healthcare-market-analysis/